CNBC Investing Club

Johnson & Johnson is a buy as shares slide after its quarterly earnings report

A bottle of Johnson & Johnson's brand lotion for sale at a pharmacy in Salt Lake City, Utah, on Thursday, Feb. 25, 2021.
George Frey | Bloomberg | Getty Images

Johnson & Johnson (JNJ) reported second-quarter earnings results on Tuesday that beat analysts' expectations.